Filippo Russo

Filippo Russo

Auto-generated profile, based on publicly available information

Filippo Russo

Institute for Cancer Research and Treatment (Italy)

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 March 2015 in Physics in Medicine & Biology
Verified
Journal Article
Closed access
AVanna vignati
anna vignati
SMSimone Mazzetti
Simone Mazzetti
Valentina GianniniValentina Giannini
Valentina Giannini
FRF Russo
F Russo
EBENRICO BOLLITO
ENRICO BOLLITO
DRDaniele Regge
Daniele Regge
To explore contrast (C) and homogeneity (H) gray-level co-occurrence matrix texture features on T2-weighted (T2w) Magnetic Resonance (MR) images and apparent diffusion coefficient (ADC) maps for predicting prostate cancer (PCa) aggressiveness, and to compare them with traditional ADC metrics for differentiating low- from intermediate/high-grade PCas. The local Ethics Committee approved this prospective study of 93 patients (median age, 65 years), who underwent 1.5 T multiparametric endorectal MR imaging before prostatectomy. Clinically significant (volume ≥0.5 ml) peripheral tumours were outlined on histological sections, contoured on T2w and ADC images, and their pathological Gleason Score (pGS) was recorded. C, H, and traditional ADC metrics (mean, median, 10th and 25th percentile) were calculated on the largest lesion slice, and correlated with the pGS through the Spearman correlation coefficient. The area under the receiver operating characteristic curve (AUC) assessed how parameters differentiate pGS = 6 from pGS ≥ 7. The dataset included 49 clinically significant PCas with a balanced distribution of pGS. The Spearman ρ and AUC values on ADC were: −0.489, 0.823 (mean); −0.522, 0.821 (median); −0.569, 0.854 (10th percentile); −0.556, 0.854 (25th percentile); −0.386, 0.871 (C); 0.533, 0.923 (H); while on T2w they were: −0.654, 0.945 (C); 0.645, 0.962 (H). AUC of H on ADC and T2w, and C on T2w were significantly higher than that of the mean ADC ( p = 0.05). H and C calculated on T2w images outperform ADC parameters in correlating with pGS and differentiating low- from intermediate/high-risk PCas, supporting the role of T2w MR imaging in assessing PCa biological aggressiveness.

4 April 2008 in CardioVascular and Interventional Radiology
Verified
Journal Article
Closed access
PDF file
GAGiovanni Carlo Anselmetti
Giovanni Carlo Anselmetti
GZGregg Zoarski
Gregg Zoarski
AMAntonio Manca
Antonio Manca
SMSalvatore Antonio Masala
Salvatore Antonio Masala
HEHaris Eminefendic
Haris Eminefendic
DRDaniele Regge
Daniele Regge

2 January 2007 in CardioVascular and Interventional Radiology
Verified
Journal Article
Closed access
PDF file
GAGiovanni Carlo Anselmetti
Giovanni Carlo Anselmetti
GCGiovanni Corrao
Giovanni Corrao
PMPatrizia Della Monica
Patrizia Della Monica
VTVincenzo Tartaglia
Vincenzo Tartaglia
AMAntonio Manca
Antonio Manca
DRDaniele Regge
Daniele Regge

20 July 2015 in BJU International
Verified
Journal Article
Open access
PDF file
FRFilippo Russo
Filippo Russo
DRDaniele Regge
Daniele Regge
EAEnrico Armando
Enrico Armando
Valentina GianniniValentina Giannini
Valentina Giannini
AVanna vignati
anna vignati
FPFrancesco Porpiglia
Francesco Porpiglia
Objective: To evaluate the sensitivity of multiparametric magnetic resonance imaging (mp‐ MRI ) for detecting prostate cancer foci, including the largest (index) lesions. Patients and Methods: In all, 115 patients with biopsy confirmed prostate cancer underwent mp‐ MRI before radical prostatectomy. A single expert radiologist recorded all prostate cancer foci including the index lesion ‘blinded’ to the pathologist's biopsy report. Stained whole‐mount histological sections were used as the reference standard. All lesions were contoured by an experienced uropathologist who assessed their volume and pathological Gleason score. All lesions with a volume of >0.5 mL and/or pathological Gleason score of >6 were defined as clinically significant prostate cancer. Multivariate analysis was used to ascertain the characteristics of lesions identified by MRI . Results: In all, 104 of 115 index lesions were correctly diagnosed by mp‐ MRI (sensitivity 90.4%; 95% confidence interval [ CI ] 83.5–95.1%), including 98/105 clinically significant index lesions (93.3%; 95% CI 86.8–97.3%), among which three of three lesions had a volume of 6. Overall, mp‐ MRI detected 131/206 lesions including 13 of 68 ‘insignificant’ prostate cancers. The multivariate logistic regression modelling showed that pathological Gleason score (odds ratio [ OR ] 11.7, 95% CI 2.3–59.8; P = 0.003) and lesion volume ( OR 4.24, 95% CI 1.3–14.7; P = 0.022) were independently associated with the detection of index lesions at MRI . Conclusions: This study shows that mp‐ MRI has a high sensitivity for detecting clinically significant prostate cancer index lesions, while having disappointing results for the detection of small‐volume, low Gleason score prostate cancer foci. Thus, mp‐ MRI could be used to stratify patients according to risk, allowing better treatment selection.

6 April 2017 in European Radiology
Verified
Journal Article
Closed access
PDF file
Valentina GianniniValentina Giannini
Valentina Giannini
SMSimone Mazzetti
Simone Mazzetti
EAEnrico Armando
Enrico Armando
SCSilvia Carabalona
Silvia Carabalona
FRFilippo Russo
Filippo Russo
DRDaniele Regge
Daniele Regge

1 July 2014 in Journal of Urology
Verified
Journal Article
Closed access
FPFrancesco Porpiglia
Francesco Porpiglia
FRFilippo Russo
Filippo Russo
MMMatteo Manfredi
Matteo Manfredi
FMFabrizio Mele
Fabrizio Mele
CFCristian Fiori
Cristian Fiori
DRDaniele Regge
Daniele Regge
In patients with a negative prostate biopsy and persistent suspicion of prostate cancer, additional analyses such as the PCA3 score, PHI and multiparametric magnetic resonance imaging have been proposed to reduce the number of unnecessary repeat biopsies. In this study we evaluate the diagnostic accuracy of PCA3, PHI, multiparametric magnetic resonance imaging and various combinations of these tests in the repeat biopsy setting. A total of 170 patients with an initial negative prostate biopsy and persistent suspicion of prostate cancer were enrolled in this prospective study. The patients underwent measurements of the total prostate specific antigen and free prostate specific antigen rate, along with PHI, PCA3 tests and multiparametric magnetic resonance imaging before standard repeat biopsy that was performed by urologists blinded to the multiparametric magnetic resonance imaging results. Multivariate logistic regression models with various combinations of PCA3, PHI and multiparametric magnetic resonance imaging were used to identify the predictors of prostate cancer with repeat biopsy, and the performance of these models was compared using ROC curves, AUC analysis and decision curve analysis. In the ROC analysis the most significant contribution was provided by multiparametric magnetic resonance imaging (AUC 0.936), which was greater than the contribution of the PHI+PCA3 model (p <0.001). In the multivariate logistic regression analysis only multiparametric magnetic resonance imaging was a significant independent predictor of prostate cancer diagnosis with repeat biopsy (p <0.001). The results of the decision curve analysis confirmed that the most significant improvement in the net benefit was provided by multiparametric magnetic resonance imaging. Multiparametric magnetic resonance imaging provides high diagnostic accuracy in identifying patients with prostate cancer in the repeat biopsy setting compared with PCA3 and PHI.